TherapeuticsMD
TXMD
#10769
Rank
โ‚น1.81 B
Marketcap
โ‚น156.84
Share price
-4.02%
Change (1 day)
31.08%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2023 (TTM): โ‚น402.66

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is โ‚น7.51. In 2022 the company made an earnings per share (EPS) of โ‚น1,179 an increase over its 2021 EPS that were of -โ‚น2,038.

EPS history for TherapeuticsMD from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น402.66-65.84%
2022โ‚น1,179-157.83%
2021-โ‚น2,038-35.22%
2020-โ‚น3,146-5.63%
2019-โ‚น3,33420.34%
2018-โ‚น2,77155.26%
2017-โ‚น1,784-19.15%
2016-โ‚น2,207-6%
2015-โ‚น2,34842.86%
2014-โ‚น1,64452.17%
2013-โ‚น1,080-41.03%
2012-โ‚น1,831-93.62%
2011-โ‚น28,718-65.57%
2010-โ‚น83,40588.66%
2009-โ‚น44,210-32.78%
2008-โ‚น65,77016.59%
2007-โ‚น56,41326.96%
2006-โ‚น44,433-11743.27%
2005โ‚น381.62-101.88%
2004-โ‚น20,288-554.77%
2003โ‚น4,461216.55%
2002โ‚น1,409-85.01%
2001โ‚น9,402369.94%
2000โ‚น2,001404.51%
1999โ‚น396.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น71.38 850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น335.33 4,363.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-โ‚น363.46-4,937.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น176.18 2,244.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-โ‚น2,374-31,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA